Prologue is designing powerful new medicines by unlocking the viral proteome. The company’s state-of-the-art DELVE™ Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021.

Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

Prologue Medicines

This department oversees the strategic planning and execution of operational activities within the organization.

Operations Management

This department focuses on leveraging data analysis, computational methods, and artificial intelligence to drive insights and innovation.

Data Science

This department focuses on scientific research and the development of innovative products and solutions.

Research and Development

This department conducts research activities and analysis to inform decision-making and strategic initiatives.

Research Division

This department focuses on the research and development of biological sciences to advance therapeutic solutions.

��

People (3)

Jobs (0)

Other teams

Data Science

Research and Development

Research Division

Translational Biology

��������

People (3)

Jobs (0)

Other teams

Data Science

Research and Development

Research Division

Translational Biology

��